- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
OneOncology to Collaborate With Employer Direct Healthcare, IDEOlogy Health
OneOncology, a national platform for independent oncology practices, announced 2 partnerships this week.
This week, OneOncology, a national platform for independent oncology practices, announced 2 partnerships.
In one, OneOncology will collaborate with Employer Direct Healthcare to revolutionize the delivery and reimbursement for cancer care, including improved community-based access to precision medicine, clinical trials, and emerging treatments such as chimeric antigen receptor (CAR) T-cell therapies. The companies will also work together to lower costs for employers by expanding OneOncology’s episode-based payment model.
In the other, OneOncology and IDEOlogy Health agreed to build a specialized oncology education system for providers to curate medical education content and delivers it through a multi-channel format. IDEOlogy Health includes IDEO Oncology and IDEO Hematology, which provides virtual and live meetings with world-renowned thought leaders.
For more, see OneOncology.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
